European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era. (Q30814158)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 June 2017

European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era. (English)

1 reference

Europe PubMed Central

26 June 2017

0 references

Pier Luigi Lopalco

object named as

Pier Luigi Lopalco

6

0 references

author name string

Adoración Navarro Torné

1

1 reference

Europe PubMed Central

26 June 2017

Joana Gomes Dias

2

1 reference

Europe PubMed Central

26 June 2017

Chantal Quinten

3

1 reference

Europe PubMed Central

26 June 2017

Frantiska Hruba

4

1 reference

Europe PubMed Central

26 June 2017

Marta Cecilia Busana

5

1 reference

Europe PubMed Central

26 June 2017

Andrew J Amato Gauci

7

1 reference

Europe PubMed Central

26 June 2017

Lucia Pastore-Celentano

8

1 reference

Europe PubMed Central

26 June 2017

ECDC country experts for pneumococcal disease

9

1 reference

Europe PubMed Central

26 June 2017

language of work or name

0 references

publication date

2 May 2014

1 reference

Europe PubMed Central

26 June 2017

1 reference

Europe PubMed Central

26 June 2017

32

1 reference

Europe PubMed Central

26 June 2017

29

1 reference

Europe PubMed Central

26 June 2017

3644-3650

1 reference

Europe PubMed Central

26 June 2017

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Surface charge of Streptococcus pneumoniae predicts serotype distribution.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Epidemiological differences among pneumococcal serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Geographical differences for pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Overview of the disease burden of invasive pneumococcal disease in Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Epidemiology and etiology of childhood pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Clonal and Capsular Types Decide Whether Pneumococci Will Act as a Primary or Opportunistic Pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Clonal Relationships between Invasive and Carriage Streptococcus pneumoniae and Serotype‐ and Clone‐Specific Differences in Invasive Disease Potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Viral Coinfection in Children Less Than Five Years Old With Invasive Pneumococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

The antimicrobial resistance profile of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

The need for prudent use of antibiotics and routine use of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

The relationship between pneumococcal serotypes and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.066

7 January 2021

Identifiers

10.1016/J.VACCINE.2014.04.066

1 reference

Europe PubMed Central

26 June 2017

1 reference

Europe PubMed Central

26 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30814158&oldid=1954766910"